AF
LLY icon

Allworth Financial’s Eli Lilly LLY Stock Holding History

Allworth Financial’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.9M Buy
66,228
+3,799
+6% +$3.85M 0.25% 58
2025
Q4 		$67.1M Sell
62,429
-149
-0.2% -$142K 0.27% 52
2025
Q3 		$47.7M Buy
62,578
+5,249
+9% +$3.91M 0.21% 65
2025
Q2 		$44.7M Buy
57,329
+33,897
+145% +$26.3M 0.21% 66
2025
Q1 		$20.1M Buy
23,432
+8,479
+57% +$7.06M 0.11% 104
2024
Q4 		$11.3M Buy
14,953
+4,303
+40% +$3.56M 0.06% 161
2024
Q3 		$9.44M Sell
10,650
-2,798
-21% -$2.52M 0.06% 146
2024
Q2 		$11.5M Buy
13,448
+6,067
+82% +$4.85M 0.07% 124
2024
Q1 		$5.74M Buy
7,381
+1,860
+34% +$1.32M 0.04% 184
2023
Q4 		$3.22M Buy
5,521
+233
+4% +$136K 0.02% 237
2023
Q3 		$2.84M Buy
5,288
+672
+15% +$346K 0.02% 237
2023
Q2 		$2.16M Buy
4,616
+702
+18% +$294K 0.02% 269
2023
Q1 		$1.34M Sell
3,914
-1,174
-23% -$396K 0.01% 315
2022
Q4 		$1.86M Buy
5,088
+2,723
+115% +$965K 0.02% 252
2022
Q3 		$765K Buy
2,365
+175
+8% +$55.4K 0.01% 361
2022
Q2 		$710K Buy
2,190
+522
+31% +$157K 0.01% 349
2022
Q1 		$478K Buy
1,668
+207
+14% +$53.3K 0.01% 403
2021
Q4 		$403K Buy
1,461
+70
+5% +$17.7K 0.01% 403
2021
Q3 		$321K Buy
1,391
+711
+105% +$175K 0.01% 395
2021
Q2 		$156K Sell
680
-685
-50% -$138K ﹤0.01% 403
2021
Q1 		$255K Sell
1,365
-139
-9% -$27.2K 0.01% 319
2020
Q4 		$254K Buy
1,504
+330
+28% +$49.3K 0.01% 257
2020
Q3 		$174K Sell
1,174
-249
-17% -$38.5K 0.01% 254
2020
Q2 		$234K Hold
1,423
– – 0.01% 227
2020
Q1 		$197K Sell
1,423
-40
-3% -$5.5K 0.01% 241
2019
Q4 		$192K Buy
1,463
+161
+12% +$18.7K 0.01% 196
2019
Q3 		$146K Buy
1,302
+75
+6% +$8.35K 0.01% 198
2019
Q2 		$136K Buy
1,227
+261
+27% +$30.7K 0.01% 200
2019
Q1 		$125K Buy
966
+3
+0.3% +$365 0.01% 214
2018
Q4 		$111K Buy
963
+776
+415% +$86.7K 0.01% 203
2018
Q3 		$20K Buy
187
+15
+9% +$1.5K ﹤0.01% 425
2018
Q2 		$15K Sell
172
-74
-30% -$6.08K ﹤0.01% 456
2018
Q1 		$19K Sell
246
-2
-0.8% -$161 ﹤0.01% 381
2017
Q4 		$21K Sell
248
-84
-25% -$7.15K ﹤0.01% 369
2017
Q3 		$28K Buy
332
+82
+33% +$6.72K ﹤0.01% 306
2017
Q2 		$21K Sell
250
-22
-8% -$1.79K ﹤0.01% 367
2017
Q1 		$23K Sell
272
-66
-20% -$5.29K ﹤0.01% 339
2016
Q4 		$25K Buy
338
+51
+18% +$3.8K ﹤0.01% 287
2016
Q3 		$23K Buy
287
+77
+37% +$6.16K ﹤0.01% 304
2016
Q2 		$17K Sell
210
-71
-25% -$5.34K ﹤0.01% 328
2016
Q1 		$20K Hold
281
– – ﹤0.01% 307
2015
Q4 		$24K Sell
281
-529
-65% -$43.9K ﹤0.01% 283
2015
Q3 		$68K Buy
810
+645
+391% +$54.5K 0.02% 176
2015
Q2 		$14K Hold
165
– – 0.01% 349
2015
Q1 		$12K Buy
+165
New +$11.7K ﹤0.01% 373

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Allworth Financial's LLY Position: Q1 2026 in Review

Allworth Financial increased its Eli Lilly (LLY) stake by 6.1% in Q1 2026, buying an estimated $3.85M and bringing the position to 66,228 shares worth $60.9M. The position accounts for 0.25% of the portfolio, ranked #58.

Allworth Financial first reported a position in LLY in Q1 2015 and has held it in 45 quarters since. The position peaked at $67.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Allworth Financial held 66,228 shares of Eli Lilly worth $60.9M as of Q1 2026.
  • Allworth Financial bought 3,799 Eli Lilly shares in Q1 2026, an estimated $3.85M.
  • Eli Lilly made up 0.25% of Allworth Financial's portfolio in Q1 2026, its #58 holding.
  • Allworth Financial first reported a position in Eli Lilly in Q1 2015 and has held it in 45 quarters since.
  • Allworth Financial's Eli Lilly position peaked at $67.1M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.